Literature DB >> 19779324

A validation study of a retrospective venous thromboembolism risk scoring method.

Vinita Bahl1, Hsou Mei Hu, Peter K Henke, Thomas W Wakefield, Darrell A Campbell, Joseph A Caprini.   

Abstract

OBJECTIVES: Validate a retrospective venous thromboembolism (VTE) risk scoring method, which was developed at the University of Michigan Health System and based on the Caprini risk assessment model, and assess the confounding effects of VTE prophylaxis.
BACKGROUND: Assessing patients for risk of VTE is essential to initiating appropriate prophylaxis and reducing the mortality and morbidity associated with deep vein thrombosis and pulmonary embolism.
METHODS: VTE risk factors were identified for 8216 inpatients from the National Surgical Quality Improvement Program using the retrospective scoring method. Logistic regression was used to calculate odds ratios (OR) for VTE within 30 days after surgery for risk factors and risk level. A bivariate probit model estimated the effects of risk while controlling for adherence to prophylaxis guidelines.
RESULTS: Distribution of the study population by risk level was highest, 52.1%; high, 36.5%; moderate, 10.4%; and low, 0.9%. Incidence of VTE within 30 days was overall 1.4%; by risk level: highest, 1.94%; high, 0.97%; moderate, 0.70%; low, 0%. Controlling for length of hospitalization (>2 d) and fiscal year, pregnancy or postpartum (OR = 8.3; 1.0-68, P < 0.05), recent sepsis (4.0; 1.4-10.9, P < 0.01), malignancy (2.3; 1.5-3.3, P < 0.01), history of VTE (2.1; 1.1-4.1, P < 0.05), and central venous access (1.8; 1.1-3.0, P < 0.05) were significantly associated with VTE. Risk level was significantly associated with VTE (1.9; 1.3-2.6, P < 0.01). The bivariate probit demonstrated significant correlation between the probability of VTE and lack of adherence to prophylaxis guidelines (rho = 0.299, P = 0.013).
CONCLUSION: The retrospective risk scoring method is valid and supports use of individual patient assessment of risk for VTE within 30 days after surgery.

Entities:  

Mesh:

Year:  2010        PMID: 19779324     DOI: 10.1097/SLA.0b013e3181b7fca6

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  114 in total

1.  Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients.

Authors:  Christopher J Pannucci; Steven H Bailey; George Dreszer; Christine Fisher Wachtman; Justin W Zumsteg; Reda M Jaber; Jennifer B Hamill; Keith M Hume; J Peter Rubin; Peter C Neligan; Loree K Kalliainen; Ronald E Hoxworth; Andrea L Pusic; Edwin G Wilkins
Journal:  J Am Coll Surg       Date:  2010-11-18       Impact factor: 6.113

2.  Venous Thromboembolism Prophylaxis in High-Risk General Surgery in Asia.

Authors:  Ngoh Chin Liew; Limi Lee
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

3.  Practice guidelines and clinical risk assessment models: is it time to reform?

Authors:  Nariman Sepehrvand; Firouz Ghaderi Pakdel; Mohammad Hosein Rahimi-Rad; Babak Moosavi-Toomatari; Shahrzad Bazargan-Hejazi
Journal:  BMC Med Inform Decis Mak       Date:  2011-10-18       Impact factor: 2.796

4.  Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.

Authors:  Christine Baumgartner; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  J Gen Intern Med       Date:  2019-06-24       Impact factor: 5.128

5.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  Venous thromboembolism risk factor assessment and prophylaxis.

Authors:  P K Henke; C J Pannucci
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

7.  A validated risk model to predict 90-day VTE events in postsurgical patients.

Authors:  Christopher J Pannucci; Sandra Laird; Justin B Dimick; Darrell A Campbell; Peter K Henke
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

8.  Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy.

Authors:  Hari Nathan; Matthew J Weiss; Gerald A Soff; Michelle Stempel; Ronald P Dematteo; Peter J Allen; T Peter Kingham; Yuman Fong; William R Jarnagin; Michael I D'Angelica
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

Review 9.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

10.  Implementation of a Comprehensive Post-Discharge Venous Thromboembolism Prophylaxis Program for Abdominal and Pelvic Surgery Patients.

Authors:  Peter A Najjar; Arin L Madenci; Cheryl K Zogg; Eric B Schneider; Christian A Dankers; Marc T Pimentel; Amrita S Chabria; Joel E Goldberg; Gaurav Sharma; Gregory Piazza; Ronald Bleday; Dennis P Orgill; Allen Kachalia
Journal:  J Am Coll Surg       Date:  2016-09-28       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.